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Abstract
Background: The constellation of elevated levels of abdominal adiposity, blood pressure, glucose,
and triglycerides and lowered high-density lipoprotein-cholesterol has been termed the metabolic
syndrome. Given the current pediatric obesity epidemic, it is perhaps not surprising that recent
reports suggest the emergence of the metabolic syndrome during childhood and adolescence. The
aim of this paper is to provide an overview of the derivation and utility of the continuous metabolic
syndrome score in pediatric epidemiologic research.
Methods/Design: Data were generated from published papers related to the topic.
Conclusion: Although there is no universal definition in children or adolescence, recent estimates
indicate that approximately 2–10% of youth possess the metabolic syndrome phenotype. Since
there is no clear definition and the prevalence rate is relatively low, several authors have derived a
continuous score representing a composite risk factor index (i.e., the metabolic syndrome score).
This paper provides an overview of the derivation and utility of the continuous metabolic syndrome
score in pediatric epidemiological research.
Background
The constellation of adverse cardiovascular disease (CVD)
and metabolic risk factors, including elevated abdominal
obesity, blood pressure, glucose, and triglycerides (TG)
and lowered high-density lipoprotein-cholesterol (HDL-
C), has been termed the metabolic syndrome [1]. Based
on the National Cholesterol Education Program Adult
Treatment Program III (ATP II) criteria [1] and the Inter-
national Diabetes Foundation criteria [2] approximately
35% and 39%, respectively, of U.S. adults possess the met-
abolic syndrome [3]. In terms of health outcomes, the
metabolic syndrome is associated with an increased risk
of all-cause mortality, CVD morbidity and mortality, and
diabetes [4].
Given the current pediatric obesity epidemic [5], it is per-
haps not surprising that recent reports indicate the emer-
gence of the metabolic syndrome during childhood and
adolescence [6-10]. Data from the United States (U.S.)
National Health and Nutrition Examination Survey
(NHANES) III (1988–1994) showed that the prevalence
rate of the metabolic syndrome was 4% in 12–19 yr old
adolescents [10]. The prevalence rate increased to 6% in
NHANES 1999–2000 [9]. Based on current estimates, > 2
million U.S. adolescents have the metabolic syndrome
phenotype [9]. Another paper using the same data (i.e.,
NHANES III) but different criteria showed that the preva-
lence rate was nearly 10% [11]. The varying prevalence
rates between studies reflects the lack of a universal defi-
nition and makes it difficult to draw conclusions. This
issue is similar in the adult literature [12]. Prevalence rates
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from representative samples in other countries are lim-
ited. The metabolic syndrome in children and adolescents
has been reported to be 6.5% in northern Mexico[13], 9%
in Korea [14], 2% in Turkey [15], and 10% in Quebec,
Canada [16]. Among obese children and adolescents the
prevalence approximates 30–50% [10,17,18].
Since there is no universal definition of the metabolic syn-
drome in children or adolescence and the prevalence rate
is relatively low, several authors [19-28] have derived a
continuous score representing a composite CVD risk fac-
tor profile or index (i.e., the metabolic syndrome score).
The purpose of this paper is to provide an overview of the
derivation and utility of the continuous metabolic syn-
drome score in pediatric epidemiologic research.
Rationale for a continuous metabolic syndrome 
score
The rationale for creating a continuous metabolic syn-
drome score stems mainly from the fact that there is no
clear definition of the metabolic syndrome in children or
adolescence and the prevalence rate is relatively low. A
low prevalence rate requires a large sample size in order to
conduct association studies. For example, in a random
sample of 500 U.S. adolescents approximately 15–50 sub-
jects would possess the metabolic syndrome based on cur-
rent estimated prevalence rates. Thus, the ability to show
links between exposures (e.g., physical activity, diet, etc.)
and the dichotomous outcome (i.e., metabolic syn-
drome) using logistic regression would limit the power to
detect an association [29].
As mentioned, several authors have derived a continuous
score to represent the clustering of components of the
metabolic syndrome (Table 1). The inclusion of these key
components (i.e., glucose, lipids, blood pressure, and adi-
posity) is supported by the results of factor analysis in
children and adolescents [16,30-32] which shows the
underlying patterns or structure among variables showing
high degrees of inter-correlation. Thus, there are common
variables that can be used to calculate a metabolic syn-
drome score. It has also been argued that a continuous
metabolic syndrome score is statistically more sensitive
and less error prone by comparison to the dichotomous
approach [20,29]. In the recent joint statement by the
American Diabetes Association and the European Associ-
ation for the Study of Diabetes [33], it was recommended
that one area of necessary research was the definition of
the metabolic syndrome based on continuous variables in
a multivariate score system.
An overview of methods used to derive the 
metabolic syndrome score
Several large-scale epidemiological studies that either
focus on cardiovascular health or include CVD risk factors
in children and adolescents have used various approaches
Table 1: Summary of approaches used to calculate the continuous metabolic syndrome score in pediatric epidemiological research.
Study Obesity Lipids Glucose or Insulin Blood Pressure Other Statistical approach
Bogolusa Heart Study 
[21]
- TC:HDL Insulin SBP Sum of the individual 
rankings by age-, sex-, 
and race-specific levels
Young Danes [28] Skinfolds TC, HDL-C, TG - SBP and DBP smoking Upper centiles
Cardiovascular Risk 
in Young Finns [22]
- TC and HDL-C - DBP Upper tertile
European Youth 
Heart Study [20]
Skinfolds HDL-C and TG Glucose and insulin Average of SBP and 
DBP
Sum of six Z scores 
divided by 6
European Youth 
Heart Study [19]
Skinfolds TG and TC:HDL-C HOMA SBP Aerobic fitness Sum of Z scores
Corpus Christi Child 
Heart Study [23]
BMI HDL-C and TG Insulin SBP 2 approaches: 1) sum 
of Z scores, and 2) 
principal components 
analysis
Quebec Family Study 
[24]
Skinfolds HDL-C, TG, and 
TC:HDL-C
Glucose MAP principal component 
analysis
Aerobic Center 
Longitudinal Study 
[27]
WC HDL-C and TG Glucose MAP Sum of age-
standardized residuals
Australian Health and 
Fitness Study [34]
WC HDL-C and TG - MAP Sum of age-
standardized residuals
Physical Activity 
across the 
Curriculum [38]
WC HDL-C and TG HOMA MAP Sum of age-, sex-, and 
race-standardized 
residuals
BMI, body mass index; WC, waist circumference; TC, total cholesterol; HDL-C, high density lipoprotein-cholesterol; TG, triglycerides; HOMA, 
homeostasis model assessment; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure.Cardiovascular Diabetology 2008, 7:17 http://www.cardiab.com/content/7/1/17
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to calculate a metabolic syndrome score (Table 1). As
shown in Table 1, the variables included in the score and
statistical approaches used to derive the score vary consid-
erably. Indicators of obesity range from the body mass
index (BMI) to skinfolds to waist circumference (WC),
whereas others do not include a measure of adiposity. The
same is true for the other components of the metabolic
syndrome. To my knowledge, Eisenmann and colleagues
are the only ones to use indicators aligned with the adult
criteria. More specifically, WC, HDL-C, TG, mean arterial
pressure (MAP) and some indicator of abnormal glucose
metabolism are used. Besides differences in the variables
included in the score, the statistical approaches used to
calculate the score also vary considerably. Previous proce-
dures include principal component analysis [23,24], Z
scores [19,20,23,25-27,34], and centile rankings [21,22].
In addition, a recent study proposed a categorical score
referred to as the Metabolic Individual Risk-factor And
Clustering Estimation (MIRACLE) score based on family
history (early cardiovascular disease, type 2 diabetes, and
hypertension), individual history (small for gestational
age and ethnic origin), clinical features (BMI, waist cir-
cumference > 90th percentile and blood pressure > 95th
percentile) and metabolic abnormalities (glucose intoler-
ance or type 2 diabetes) [35].
An example of the calculation of the metabolic 
syndrome score using the Z score method
In the past few years, we have used the Z score approach
to calculate the metabolic syndrome score. In this section,
some general considerations and the specific methodol-
ogy of this approach are highlighted.
Step 1: Choice of variables to be included in the metabolic 
syndrome score
The first step is to choose the variables to be represented
in the score. As mentioned, several variables have been
used in the calculation of the metabolic syndrome score.
In the opinion of this author, the variables should reflect
the adult metabolic syndrome criteria as discussed above.
However, some data sets may lack some of the variables
consistent with the adult criteria. For example, fasting
blood glucose or WC may not have been measured in
some studies. In the case where WC is not available, the
BMI or skinfold thickness has been used. Another issue we
have faced is deciding upon which blood pressure varia-
ble should be used. Instead of using both systolic and
diastolic blood pressure (or the average – e.g., Brage et
al.), we have chosen MAP to represent blood pressure.
Likewise, the inclusion of glucose and/or insulin is a chal-
lenge. Since fasting blood glucose is typically normal in
youth and even in overweight youth [10], other parame-
ters of insulin resistance should be used. In recent analy-
ses, we and the European Youth Heart Study [19] chose to
represent insulin resistance as the homeostasis assessment
model of insulin resistance (HOMA)[36].
Step 2: Choice of variables included in the standardization 
process
In our previous studies, the individual risk factors have
been regressed onto age to account for any age-related dif-
ferences in the risk factors. Unfortunately, we have not
been able to account for biological maturity status. It is
recommended to include a biological maturity indicator
in this procedure since maturity status also influences the
individual risk factors. In addition, other demographic
variables, such as sex, ethnicity, and socio-economic sta-
tus, can be considered here. Again, a decision needs to be
made regarding which variables to include in this step.
When sufficient numbers of boys and girls or ethnic
groups are available, separate analyses can be conducted
for sex and ethnicity. On the other hand, if the sample size
for these groups is insufficient for group specific analyses,
the individual risk factors can be standardized by age, sex,
and ethnicity.
Table 2: Example of data and age-, sex-, and race-standardized Z score used in the derivation of the metabolic syndrome score.
Measured values Standardized residuals (Z scores)
Subject Age Race WC MAP HOMA TG HDL Z_WC Z_MAP Z_HOMA Z_TG Z_HDL MetS Score
1 8 White 63.8 76.0 0.53 48 47 0.55 -0.49 -0.52 -1.01 0.66 -0.81
2 8 White 70.5 85.3 3.33 119 36 1.36 0.72 1.04 1.53 1.63 6.29
3 8 Hispanic 78.5 80.0 3.32 104 58 1.99 -0.03 0.51 0.96 -0.06 3.37
4 7 Black 45.8 72.0 0.56 62 71 -1.56 -0.99 -0.60 -0.39 -1.49 -5.02
*Mean 7.7 59.3 79.7 1.58 75.5 54.4
*SD 0.6 8.7 7.8 2.06 26.9 11.0
WC, waist circumference (cm); MAP, mean arterial pressure (mm Hg); HOMA, homeostasis assessment model of insulin resistance; TG, 
triglyerides (mg/dl); HDL, high density lipoprotein-cholesterol (mg/dl); Z, z score; MetS score, metabolic syndrome score.
*Values indicate sample mean and standard deviation (SD) (n = 193 girls).Cardiovascular Diabetology 2008, 7:17 http://www.cardiab.com/content/7/1/17
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Step 3: Calculation of individual Z scores and the 
metabolic syndrome score
Once the decision has been made as to which variables
will be included in the score and which variables will be
used to standardize the score, the statistical procedures
can then be performed. The initial statistical procedure is
to standardize the individual metabolic syndrome varia-
bles (e.g., WC, MAP, HOMA, HDL-C, and TG) by regress-
ing them onto the selected demographic variables (e.g.,
age, sex, ethnicity, etc.). Once each metabolic syndrome
variable has been regressed onto the independent varia-
bles, the standardized residual is saved (e.g., Z_WC, etc.).
Since the standardized HDL-C is inversely related to met-
abolic risk it is multiplied by -1. The standardized residu-
als (Z-scores) for the individual risk factors (WC, MAP,
HDL-C, TG, and HOMA) are summed to create the meta-
bolic syndrome score. A higher score is indicative of a less
favorable metabolic syndrome profile.
For a specific example, Table 2 shows demographic infor-
mation, values for individual risk factors and the Z scores
for 4 girls participating in a study that included 193 girls
and 182 boys ages 7 to 9 years of age [8]. The individual Z
scores and the metabolic syndrome score are also illus-
trated in Figure 1. The metabolic syndrome score was
derived by calculating age-, sex-, and race-specific Z scores
for WC, MAP, HOMA, HDL-C, and TG and summing the
individual Z scores as described above. The highest meta-
bolic syndrome scores are in subjects 3 and 4, both of
whom were obese. Subject 2 displayed positive Z scores
for each risk factor. Subject 1 displayed the lowest meta-
bolic syndrome score and had negative Z scores for each
risk factor. It should be noted that a subject could possess
both positive and negative Z scores for various risk factors
(Subject 1).
Limitations of the metabolic syndrome score
A major limitation to the metabolic syndrome score pre-
sented in previous studies is that it is sample specific.
Therefore, the mean metabolic syndrome score derived in
one study cannot be compared to other studies unless the
demographic characteristics, distribution of data, and the
measures of central tendency and variability are similar in
the two samples. The other limitations of previous
research have already been mentioned and include the use
of different variables and statistical procedures. It is also
important to note that most previous studies have not
taken into consideration the age- or maturity-related vari-
ation in metabolic syndrome risk factors. Finally, the
weighting of each individual variable to the final score is
considered equal in the Z score approach. In contrast, fac-
tor analysis and principal components analysis calculate
the loadings of each variable independently.
There is considerable need to develop a universal defini-
tion of the pediatric metabolic syndrome [37]. In an excel-
lent review, Cruz and Goran [37] suggested that the same
risk factor variables that are used in the adult definition
also be used in children so that the definition is consistent
across the lifespan for purposes of tracking. In addition, if
epidemiological studies are to use the continuous meta-
bolic syndrome score, a standardized method of calculat-
ing the score may prove beneficial for comparing studies.
An alternative approach to the sample-specific Z score
approach highlighted here may be to compare individual
risk factor value to the population median (i.e., 85th per-
centile of age- and sex-specific reference values) or clinical
cut-points.
Utility of the metabolic syndrome score in 
pediatric epidemiological research
Several authors have shown significant differences or
associations between various exposures and the metabolic
syndrome score. For example, results from the Corpus
Christi Child Heart Study indicated higher metabolic syn-
drome scores in Mexican-American boys and girls com-
pared to White boys and girls [23]. Recent studies also
show that habitual physical activity and aerobic fitness are
inversely associated with the metabolic syndrome score
[19,20,25-27,34]. Eisenmann and colleagues
[25,26,34,38] have also shown that aerobic fitness atten-
uates the metabolic syndrome score among high fat chil-
dren and adolescents. The metabolic syndrome score has
also been shown to track from childhood/adolescence
into young adulthood [21,22,24,27]. Other studies show
an association between markers of the metabolic syn-
Illustrative example of the age-, sex-, and race-standardized Z  score used in the derivation of the metabolic syndrome  score Figure 1
Illustrative example of the age-, sex-, and race-stand-
ardized Z score used in the derivation of the meta-
bolic syndrome score. See table 2 for abbreviations and 
measured values.
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drome in childhood and type 2 diabetes and cardiovascu-
lar disease morbidities in adulthood [39,40]. These latter
findings hold importance to the predictive utility of the
score on disease outcomes and confirms that the defini-
tion of the metabolic syndrome in youth and the calcula-
tion of the metabolic syndrome score should include the
same variables as those in the adult criteria for the meta-
bolic syndrome [37].
Summary and recommendations
This paper provides an overview of the derivation and
utility of the continuous metabolic syndrome score in
pediatric epidemiology. The continuous score is impor-
tant in epidemiological research since there is no univer-
sal definition of the metabolic syndrome for children or
adolescents and the prevalence rate is relatively low. The
score allows each subject to have a continuous value with
lower values indicating a better metabolic syndrome pro-
file and higher values indicating a poorer metabolic syn-
drome profile compared to the sample studied. Several
variables and statistical procedures have been used to
derive the metabolic syndrome score in previous research
(Table 1). It is recommended that the five key metabolic
syndrome variables be used in the calculation of the score
in future research. These variables include 1) central obes-
ity (as measured by WC – or BMI and/or skin fold thick-
ness if WC is not available), 2) low HDL-C, 3) elevated
TG, 4) elevated BP (systolic and/or diastolic and/or MAP),
and 5) abnormal glucose metabolism (impaired fasting
glucose, impaired glucose tolerance, and/or HOMA). Fur-
thermore, the individual components should be age-
standardized (and maturity-standardized, if available)
given the influence of growth and maturation on the
development of the metabolic risk factors.
Future research is needed to validate the current method-
ologies used on deriving the metabolic syndrome score in
children and adolescents. Recently, Winjndaele et al [41]
showed a continuous metabolic syndrome score derived
from principal component analysis was higher in adult
subjects with the metabolic syndrome and that the score
increased progressively with increasing number of adverse
risk factors. Although the metabolic syndrome score
tracks from adolescence into adulthood [24,42], associa-
tion studies using established cohorts that link the meta-
bolic syndrome score during childhood and adolescence
with adult-diagnosed metabolic syndrome, type 2 diabe-
tes, atherosclerosis and CVD mortality are required. If a
simple and practical yet valid method utilizing criterion-
reference standards can be developed, then the metabolic
syndrome score could be used conventionally in pediatric
epidemiological research, clinical medicine, and public
health to better understand the prevention, diagnosis, and
treatment of this emerging pediatric condition.
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